J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Vol 293 pp 247-284
Copyright © 1979 by The Physiological Society
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colquhoun, D
Right arrow Articles by Sheridan, R E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colquhoun, D
Right arrow Articles by Sheridan, R E

The actions of tubocurarine at the frog neuromuscular junction.

D Colquhoun, F Dreyer and R E Sheridan

1. The action of tubocurarine on voltage-clamped frog muscle end-plates has been re-examined by means (a) equilibrium dose-ratio measurements, (b) current fluctuation measurements and (c) voltage-jump relaxation measurements. 2. The equilibrium measurements can be interpreted as implying that tubocurarine has (a) a competitive blocking action, with a dissociation constant of 0.34 microM, which is not dependent on membrane potential, and (b) an additional voltage-dependent blocking action. 3. In the presence of tubocurarine two kinetic components can be seen. The faster one is similar to, but rather faster than, the normal ion channel closing rate. The other is much slower (1--3 sec), and, in relaxation experiments it is in the opposite direction to the fast relaxation. 4. A number of alternative explanations for the results are discussed. The mechanism that fits them best appears to be a combination of competitive block (or block of shut channels), with a strongly voltage-dependent block of open ion channels by tubocurarine. Estimates of the rate constants for channel blocking (and their voltage dependence) are derived. From these estimates the dissociation constant for the binding of tubocurarine to open channels appears to be roughly 0.12 microM at --70 mV and 0.02 microM at --12 mV. 5. Several potential sources of error in the experiments, and in their interpretation, are discussed. The most serious of these are problems associated with diffusion in the small volume of the synaptic cleft, viz. (a) changes in cleft concentration consequent on changes in binding, and (b) ionophoretic flux of antagonist and agonist into the synaptic cleft.




This article has been cited by other articles:


Home page
J. Gen. Physiol.Home page
Y. Purohit and C. Grosman
Block of Muscle Nicotinic Receptors by Choline Suggests that the Activation and Desensitization Gates Act as Distinct Molecular Entities
J. Gen. Physiol., May 30, 2006; 127(6): 703 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. E Nikolsky, F. Vyskocil, E. A Bukharaeva, D. Samigullin, and L. G Magazanik
Cholinergic regulation of the evoked quantal release at frog neuromuscular junction
J. Physiol., October 1, 2004; 560(1): 77 - 88.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
W. Li and R. W. Aldrich
Unique Inner Pore Properties of BK Channels Revealed by Quaternary Ammonium Block
J. Gen. Physiol., June 28, 2004; 124(1): 43 - 57.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Demazumder and J. P. Dilger
The Kinetics of Competitive Antagonism by Cisatracurium of Embryonic and Adult Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2001; 60(4): 797 - 807.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
Y. Saitoh, K. Kaneda, Y. Fujii, and T. Oshima
Nicorandil accelerates recovery of neuromuscular block caused by vecuronium
Can J Anesth, January 1, 2001; 48(1): 28 - 33.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. G. Hope, D. Belelli, I. D. Mair, J. J. Lambert, and J. A. Peters
Molecular Determinants of (+)-Tubocurarine Binding at Recombinant 5-Hydroxytryptamine3A Receptor Subunits
Mol. Pharmacol., June 1, 1999; 55(6): 1037 - 1043.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
R. Zwart and H. P. M. Vijverberg
Four Pharmacologically Distinct Subtypes of alpha 4beta 2 Nicotinic Acetylcholine Receptor Expressed in Xenopus laevis Oocytes
Mol. Pharmacol., December 1, 1998; 54(6): 1124 - 1131.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
B. Buisson and D. Bertrand
Open-Channel Blockers at the Human alpha 4beta 2 Neuronal Nicotinic Acetylcholine Receptor
Mol. Pharmacol., March 1, 1998; 53(3): 555 - 563.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 The Physiological Society.